"Designing Growth Strategies is in our DNA"

Europe Dry Eye Syndrome Market Size, Share & COVID-19 Impact Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2023-2030

Last Updated: April 08, 2024 | Format: PDF | Report ID: FBI107540



Play Audio Listen to Audio Version

Europe is the second largest region in the global dry eye syndrome market. It is projected to grow at a CAGR of 6.1% during the forecast period. The global market for dry eye syndrome is projected to grow from USD 6.61 billion in 2022 to USD 11.26 billion by 2030.

The growing adoption of innovative therapeutics for treating dry eye syndrome has led market players in the region to accelerate their R&D activities. These companies are focusing on getting regulatory approvals to meet the growing demand of patients suffering from dry eye syndrome. For instance, in February 2023, Novaliq GmbH, a Germany-based company, filed the Marketing authorization Application (MAA) for CyclASol (ciclosporin ophthalmic solution), an anti-inflammatory product for the treatment of Dry Eye Disease (DED) in the European Union. Similar efforts from leading players will accelerate the Europe market growth during the forecast duration.

Our report on the Europe dry eye syndrome market covers the following countries/regions – the U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe.


Rising Prevalence of Dry Eye Coupled with Rising Geriatric Population to Foster Market Growth

Dry eye syndrome is a commonly occurring ocular condition and has become a frequent reason for patients to seek eye care. Studies have observed that the prevalence of suffering from this condition increases with growing age as well as among patients with existing chronic conditions such as diabetes, rheumatoid arthritis, thyroid disorders, and many more. According to a study published by the BMJ Journal in February 2021, the overall prevalence of dry eye disease was 9.6% amongst a female cohort in the U.K. while the prevalence of reported symptoms of this condition in the previous three months was 20.8%. The study further stated that the prevalence of this condition in the U.K. is higher among women as compared to men and increases with age, with the majority of the individuals aged above 50 years.  


New Product Launches to Accelerate the Europe Dry Eye Syndrome Market Growth

One of the crucial factors driving the market growth is the focus of market players on getting regulatory approvals for their products and introducing novel therapeutic measures in the market. These companies are also actively investing in supporting and accelerating the development of pipeline candidates. This provides wider treatment options to the patient population and also increases the adoption of these products, which will augment the market size.

  • For instance, in January 2022, Alcon launched the Systane Complete Preservative-Free Lubricant Eye Drops in Europe. Systane is an artificial tear brand and is available in multi-dose bottles. This helps the company to expand its footprint in the fast-growing artificial tears category.


Request a Free sample to learn more about this report.

Stringent Regulatory Requirement for Approval to Hamper Growth 

One of the key restraining factors for the market growth is the stringent regulatory process for getting approval for products indicated for the treatment of this condition. The stringent regulatory process influences the investment strategies of companies involved in this market as it leads to delays in the commercial launches of products and restricts its market presence. Despite this condition, being a commonly occurring disease, this encourages market players to withdraw their products from the market to continue their sustainable revenue growth. Furthermore, the high cost of specialty dry eye products restricts the market growth.

  • For instance, in June 2020, Novartis Europharm Ltd. withdrew its application for marketing authorization of Xiidra (Liftegrast) for the treatment of dry eye disease from Europe. The company decided to discontinue its product, the objections raised by European Medicines Agency (EMA) cannot be resolved in the given time frame. Hence, such factors are expected to hinder the growth of the market in the forthcoming years.


In terms of the competitive landscape, Alcon and Santen Pharmaceutical Co., Ltd. are some of the prominent players dominating the Europe dry eye syndrome market share, owing to the strategic expansion of their business by getting regulatory approvals to introduce novel products, which will lead to the market growth in the forecast period.

Other players, such as Sun Pharmaceuticals Industries, Inc., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Vision Care, Inc., and Sentiss Pharma Pvt. Ltd., also held significant markets due to their active investment in supporting and accelerating the development of their pipeline candidates. These companies are also focused on strengthening their product portfolio and distribution network through strategic collaboration and partnerships to increase their market share in the Europe market.



  • October 2022: Oculis, SA entered into a definitive business combination agreement with European Biotech Acquisition Corp. to accelerate the development of Oculis’s ophthalmology pipeline candidates.

  • February 2022: Ntc s.r.l. entered into an exclusive agreement with Laboratoires Théa to grant marketing rights for its innovative preservative-free lubricating and lenitive eye spray in Western Europe.

  • May 2022: Bausch + Lomb in collaboration with a Germany-based company, Novaliq GmbH announced positive results for its phase three investigational treatment NOV03, which is under clinical trial to treat signs and symptoms of dry eye disease associated with Meibomian Gland Dysfunction.


To gain extensive insights into the market, Request for Customization

The Europe dry eye syndrome market research report provides qualitative and quantitative insights on the market and a detailed analysis of the Europe market size & growth rate for all possible segments in the market. Along with the Europe market forecast, the research report provides an elaborative analysis on the basis of distribution channel and competitive landscape. Various key insights presented in the report are prevalence of this type of syndrome such as key countries, key industry developments, new product launches, reimbursement policies, regulatory scenario, healthcare industry overview, by key countries, and the impact of COVID-19 pandemic on the market.

Report Scope & Segmentation



Study Period


Base Year


Estimated Year


Forecast Period


Historical Period


Growth Rate

CAGR of 6.1% from 2023 to 2030


Value (USD billion)


By Product, Distribution Channel, and Country/Sub-Region

By Product

  • Anti-inflammatory Products

    • Cyclosporin

    • Corticosteroids

    • Others

  • Artificial Tears and Lubricants

  • Others

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

  • Others

By Country/ Sub-Region

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Scandinavia

  • Rest of Europe












Frequently Asked Questions

Growing at a CAGR of 6.1%, the market will exhibit steady growth in the forecast period (2023-2030).

The rising prevalence of this condition and increasing demand for effective therapeutic measure are the major factors driving the growth of the market.

Alcon and Santen Pharmaceutical Co., Ltd. are the major market players in the Europe market.

Germany dominated the market in 2022.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 109

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.